Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial Meeting Abstract
| Authors: | Subbiah, V.; Gainor, J. F.; Oxnard, G. R.; Tan, D. S. W.; Owen, D. H.; Cho, B. C.; Loong, H. H. F.; McCoach, C. E.; Weiss, J.; Kim, Y.; Bazhenova, L.; Park, K.; Daga, H.; Besse, B.; Gautschi, O.; Ng, S.; Huang, X.; Drilon, A. E. |
| Abstract Title: | Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368303421 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.9516 |
| Notes: | Meeting Abstract: 9516 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
